Maxlive Pharmaceuticals Private Limited

Maxlive Pharmaceuticals Private Limited - pharma in Sahibabad, Uttar Pradesh, India. FY 2026 financials & compliance.
CIN U24233UP2011PTC048133 Incorporated 29 December 2011 ROC Kanpur HQ Sahibabad, Uttar Pradesh, India
Active Private Limited Company pharma MSME · Small
Revenue · FY 2025
₹7.38 Cr
▲ 114% YoY
Net loss · FY 2025
₹3.03 Lakh
Net margin -0.4%
EBITDA · FY 2025
₹30.84 Lakh
EBITDA margin 4.2%
Authorised capital
₹30 Lakh
Registered with MCA
Paid-up capital
₹30 Lakh
Issued & subscribed
Open charges
₹12.59 Cr
Satisfied ₹80 Lakh
Company age
15 yrs
Est. 2011
Directors on board
2
As per MCA filings

About Maxlive Pharmaceuticals Private Limited

Data last updated:

Maxlive Pharmaceuticals Private Limited is a private limited company based in Sahibabad, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 December 2011 and has been in existence for over 15 years.

The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24233UP2011PTC048133. Its GSTIN is 09AAHCM6935E1Z9 (Uttar Pradesh).

The company has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹30 Lakh. It is led by directors Manoj Kumar and Ankur Vashishtha.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No. II – 7/6 Ground Floor Block – 7 Sector – 2 Rajendra Nagar, Sahibabad, Uttar Pradesh, India – 201005.

As per the financials filed for FY 2025, the company reported a revenue of ₹7.38 Cr, a growth of 114% compared to the previous year. For the same year it recorded a net loss of ₹3.03 Lakh (net margin -0.4%) and EBITDA of ₹30.84 Lakh (EBITDA margin 4.2%). Revenue has declined at a compounded annual rate (CAGR) of 2% over three years and 2% over five years.

As per MCA filings, the company has open charges of ₹12.59 Cr and satisfied charges of ₹80 Lakh on record.

Maxlive Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-29-0022714). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24233UP2011PTC048133
Registration Number 048133
Incorporation Date 29 December 2011
ROC Kanpur
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-UP-29-0022714

Recognitions & Rankings of Maxlive Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Small (2023-24)
Udyam number
UDYAM-UP-29-0022714

Contact details

Maxlive Pharmaceuticals Private Limited's registered office is in Sahibabad, Uttar Pradesh. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Shop No. II – 7/6 Ground Floor Block – 7 Sector – 2 Rajendra Nagar, Sahibabad, Uttar Pradesh, India – 201005
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Maxlive Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Maxlive Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Maxlive Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Maxlive Pharmaceuticals Private Limited, buy the company report.

Financials of Maxlive Pharmaceuticals Private Limited

FY 2025 filings available

Maxlive Pharmaceuticals Private Limited reported revenue of ₹7.38 Cr (up 114% YoY) for FY 2025.

Revenue · FY 2025
₹7.38 Cr ▲ 114%
Net loss · FY 2025
₹3.03 Lakh margin -0.4%
EBITDA · FY 2025
₹30.84 Lakh margin 4.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 114%
3 years · compounded
▲ 2%
5 years · compounded
▼ 2%
EBITDA CAGR growth
1 year
▲ 1%
3 years · compounded
▼ 8%

Revenue rose 114% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 2%. EBITDA rose 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹30.84 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹3.03 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin4.2%
Net Profit Margin-0.4%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Maxlive Pharmaceuticals Private Limited, buy the company report.

Board of directors of Maxlive Pharmaceuticals Private Limited

Maxlive Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Manoj KumarDirector29 Dec 201114 Years 10 MonthsCurrent
Ankur VashishthaDirector03 Nov 20188 Years 0 MonthsCurrent

Peer comparison

Maxlive Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Vyonics Healthcare India Private Limited₹7.39 Cr (FY 2025)4.0%Delhi, India
Everva Lifecare Private Limited₹7.39 Cr (FY 2025)30.0%Panchkula, Haryana, India
Navodaya Pharmaceuticals Private Limited₹7.38 Cr (FY 2024)-19.0%Noida, Uttar Pradesh, India
Vayuputra Marketing Private Limited₹7.38 Cr (FY 2016)-7.0%Tamil Nadu, India
Maxlive Pharmaceuticals Private Limitedthis company₹7.38 Cr (FY 2025)-₹3.03 Lakh-0.4%114.0%Sahibabad, Uttar Pradesh, India
Optho Pharma Private Limited₹7.37 Cr (FY 2024)-9.0%Allahabad, Uttar Pradesh, India
Ravenmac Pharmaceuticals Private Limited₹7.34 Cr (FY 2025)17.0%Amritsar, Punjab, India

To see the full peer comparison of Maxlive Pharmaceuticals Private Limited, buy the company report.

Auditor

Maxlive Pharmaceuticals Private Limited is audited by Praveen Amar & CO. for the financial year 2023.

Auditor firmFinancial yearFirm registration number
Praveen Amar & CO.FY 2023041096N

Shareholding

The shareholding of Maxlive Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Maxlive Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹12.59 Cr
Satisfied charges
₹80 Lakh
Breakdown by lending institutions
Others₹9.10 Cr
Hdfc Bank Limited₹3.00 Cr
Indian Bank₹0.49 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
13 Oct 2025101177118Others₹1.78 CrOpen
19 Oct 2024100988618Others₹4.22 CrOpen
15 Mar 2024100900510Others₹10.08 LakhOpen
14 Jun 2023100735788Others₹3 CrOpen
06 Oct 2020100384396Hdfc Bank Limited₹3 CrOpen

To see the full charge records of Maxlive Pharmaceuticals Private Limited, buy the company report.

Total charge records: 7 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Maxlive Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Maxlive Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
09AAHCM6935E1Z9Uttar PradeshActive01 Jul 2017

To see the full GST registrations and return filing status of Maxlive Pharmaceuticals Private Limited, buy the company report.

Recent activity

Maxlive Pharmaceuticals Private Limited has 4 board changes on record since 2011: 2 appointments and 2 cessations. The latest: Ankur Vashishtha ceased to be Additional Director on 30 Sep 2019.

Charges
A charge with Others of Rs. 422.00 Lakh registered on 19 Oct 2024 with Charge ID 100988618 was modified on 06 Nov 2025.
Charges
A charge with Others amounted to Rs. 178.00 Lakh with Charge ID 101177118 was registered on 13 Oct 2025.
AGM
Maxlive Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Maxlive Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur.
Charges
A charge with Others amounted to Rs. 422.00 Lakh with Charge ID 100988618 was registered on 19 Oct 2024.
Charges
A charge with Others amounted to Rs. 10.08 Lakh with Charge ID 100900510 was registered on 15 Mar 2024.
Charges
A charge with Others amounted to Rs. 300.00 Lakh with Charge ID 100735788 was registered on 14 Jun 2023.
Charges
A charge registered on 03 Feb 2020 via Charge ID 100325937 with Others was fully satisfied on 28 Feb 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 300.00 Lakh with Charge ID 100384396 was registered on 06 Oct 2020.
Charges
A charge with Others amounted to Rs. 80.00 Lakh with Charge ID 100325937 was registered on 03 Feb 2020.
Charges
A charge with Indian Bank amounted to Rs. 49.00 Lakh with Charge ID 100318520 was registered on 20 Jan 2020.
Ceased
Ankur Vashishtha ceased to be Additional Director.

4 earlier events are in the company report.

Frequently asked questions

Maxlive Pharmaceuticals is an active private limited company based in Sahibabad, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 December 2011 (15+ years old) and is registered under CIN U24233UP2011PTC048133.

Maxlive Pharmaceuticals has 2 current directors:

The latest financial statements of Maxlive Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Maxlive Pharmaceuticals is 09AAHCM6935E1Z9, registered in Uttar Pradesh.

The CIN (Corporate Identification Number) of Maxlive Pharmaceuticals is U24233UP2011PTC048133. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Maxlive Pharmaceuticals was incorporated on 29 December 2011, making it 15+ years old. It is registered with the Registrar of Companies, Kanpur.

The peers of Maxlive Pharmaceuticals by revenue are Vyonics Healthcare India Private Limited, Everva Lifecare Private Limited, Navodaya Pharmaceuticals Private Limited, Vayuputra Marketing Private Limited, Optho Pharma Private Limited and 1 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).

Ankur Vashishtha ceased to be Additional Director on 30 Sep 2019. Amit Singh ceased to be Director on 03 Nov 2018. Ankur Vashishtha was appointed as Director on 03 Nov 2018. Maxlive Pharmaceuticals has 4 board changes on record in total.

Yes, Maxlive Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-UP-29-0022714).

The registered office of Maxlive Pharmaceuticals is at Shop No. II – 76 Ground Floor Block – 7 Sector – 2 Rajendra Nagar, Sahibabad, Uttar Pradesh, India – 201005.

Maxlive Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.